TABLE 1.
Demographic, anthropometric and biochemical characteristics of studied patients (n = 70)
| Variable | |
|---|---|
| Female | 41 (58.6) |
| Male | 29 (41.4) |
| Age, years | 36.6 ± 12.1 |
| BMI, kg/m2 | 24.1 (22.0–27.3) |
| Men | 24.5 (23.0–28.3) |
| Women | 24.0 ± 3.6 |
| Waist circumference, cm | |
| Men | 86.6 ± 11.7 |
| Women | 79.1 ± 10.2 |
| Waist‐to hip‐ratio | 0.87 ± 0.08 |
| Diabetes duration, years | 23.6 ± 12.2 |
| Age at diagnosis, years | 13.5 ± 6.5 |
| Blood pressure, mmHg | |
| Systolic | 116 (110–129) |
| Diastolic | 70 (70–80) |
| eGDR, mg/kg/min | 8.60 (6.59–9.65) |
| Total insulin dose, U | 41.0 ± 16.4 |
| Total insulin dose, U/kg | 0.61 (0.45–0.78) |
| Retinopathy | 26 (37.1) |
| Neuropathy | 25 (35.7) |
| Nephropathy | 31 (44.3) |
| Coronary heart disease | 1 (1.4) |
| Stroke | 0 |
| Peripheral vascular disease | 1 (1.4) |
| Lipid‐lowering drugs | 37 (55.2) |
| Antihypertensive drugs | 33.3 (23) |
| Aspirin | 9 (13.0) |
| Glucose, mg/dl | 179.1 ± 84.6 |
| HbA1c, % | 8.6 ± 2.1 |
| Uric acid, mg/dl | 4.5 ± 1.6 |
| Creatinine, mg/dl | 1.44 ± 1.95 |
| Total cholesterol, mg/dl | 183 ± 38 |
| Triglycerides, mg/dl | 102 (84–137) |
| HDL‐C, mg/dl | |
| Men | 53.0 ± 12.0 |
| Women | 60.4 ± 16.3 |
| LDL‐C, mg/dl | 110 ± 33 |
| eGFR, ml/min/1.73 m2 | 107.5 (67.8.0–130.2) |
| UACR, mg/g | 12.1 (4.7–51.1) |
Data expressed as frequencies (%), mean (SD) or median (IQR), as appropriate.
Abbreviations: BMI, body mass index, eGDR, estimated glucose disposal rate, HDL‐C, high‐density lipoprotein cholesterol, LDL‐C, low‐density lipoprotein cholesterol, eGFR, estimated glomerular filtration rate, UACR, urinary albumin‐creatine ratio.